File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Article: B cell-targeted therapy for rheumatoid arthritis

TitleB cell-targeted therapy for rheumatoid arthritis
類風濕關節炎的B細胞靶向治療進展
Authors
Issue Date2011
Publisher上海市免疫學院研究所. The Journal's web site is located at http://shmy.chinajournal.net.cn/
Citation
現代免疫學, 2011, v. 31 n. 3, p. 180-182 How to Cite?
Current Immunology, 2011, v. 31 n. 3, p. 180-182 How to Cite?
Abstract類風濕關節炎(rheumatoid arthritis,RA)是以慢性滑膜炎癥、進行性骨質破壞和關節功能喪失為特征的自身免疫性疾病。目前針對RA的治療以免疫抑制劑為主。近年來生物制劑如TNF-α、IL-6單抗等應用于臨床,但均不能完全控制炎癥進展,且存在病人耐受性差、易發生結核等繼發感染的副作用。因此,深入探討RA的免疫病理機制及研發新型免疫治疗方法对于RA 的临床治疗有重要意义。
Persistent Identifierhttp://hdl.handle.net/10722/137629
ISSN

 

DC FieldValueLanguage
dc.contributor.authorLu, Len_US
dc.date.accessioned2011-08-26T14:29:43Z-
dc.date.available2011-08-26T14:29:43Z-
dc.date.issued2011en_US
dc.identifier.citation現代免疫學, 2011, v. 31 n. 3, p. 180-182zh_HK
dc.identifier.citationCurrent Immunology, 2011, v. 31 n. 3, p. 180-182-
dc.identifier.issn1001-2478-
dc.identifier.urihttp://hdl.handle.net/10722/137629-
dc.description.abstract類風濕關節炎(rheumatoid arthritis,RA)是以慢性滑膜炎癥、進行性骨質破壞和關節功能喪失為特征的自身免疫性疾病。目前針對RA的治療以免疫抑制劑為主。近年來生物制劑如TNF-α、IL-6單抗等應用于臨床,但均不能完全控制炎癥進展,且存在病人耐受性差、易發生結核等繼發感染的副作用。因此,深入探討RA的免疫病理機制及研發新型免疫治疗方法对于RA 的临床治疗有重要意义。zh_HK
dc.languagechien_US
dc.publisher上海市免疫學院研究所. The Journal's web site is located at http://shmy.chinajournal.net.cn/zh_HK
dc.relation.ispartof現代免疫學zh_HK
dc.relation.ispartofCurrent Immunology-
dc.titleB cell-targeted therapy for rheumatoid arthritisen_US
dc.title類風濕關節炎的B細胞靶向治療進展zh_HK
dc.typeArticleen_US
dc.identifier.emailLu, L: liweilu@hkucc.hku.hken_US
dc.identifier.authorityLu, L=rp00477en_US
dc.identifier.hkuros191300en_US
dc.identifier.volume31en_US
dc.identifier.issue3-
dc.identifier.spage180en_US
dc.identifier.epage182en_US
dc.publisher.placeChina-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats